Jacobs Levy Equity Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Jacobs Levy Equity Management’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200,425	Closed	-$1.62M	–	1100
2021 Q3	$1.62M	Buy	200,425 +5,205	+3%	+$44.6K	0.01%	655
2021 Q2	$1.92M	Buy	195,220 +113,948	+140%	+$926K	0.01%	606
2021 Q1	$717K	Buy	81,272 +46,306	+132%	+$508K	0.01%	805
2020 Q4	$358K	Sell	34,966 -62	-0.2%	-$678	﹤0.01%	895
2020 Q3	$317K	Sell	35,028 -1,133	-3%	-$8.97K	﹤0.01%	880
2020 Q2	$258K	Buy	+36,161	New	+$384K	﹤0.01%	908

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management's GRTX Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 200,425 shares — an estimated $1.62M sold.

Jacobs Levy Equity Management first reported a position in GRTX in Q2 2020 and held it in 6 quarters. The position peaked at $1.92M in Q2 2021. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

Jacobs Levy Equity Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 200,425 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $1.62M.
Jacobs Levy Equity Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
Jacobs Levy Equity Management's Galera Therapeutics, Inc. Common Stock position peaked at $1.92M in Q2 2021.
44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.